| Literature DB >> 23451144 |
Vincent Masse1, Louis Valiquette, Soraya Boukhoudmi, Francis Bonenfant, Yasmine Talab, Jean-Christophe Carvalho, Isabelle Alarie, Nathalie Carrier, Paul Farand.
Abstract
BACKGROUND: Patient isolation using contact precautions has gained widespread use to halt MRSA transmission, however supportive data is scarce and concerns regarding patient safety and satisfaction have been raised. At our institution, MRSA patients are isolated on a dedicated ward (cohort isolation), rather than in separate rooms. Our objectives were (1) to determine the proportion of bedside medical visits to patients on an isolation ward, (2) to quantify complications in those patients and (3) to determine if those complications are related to isolation and if they can be prevented.Entities:
Mesh:
Year: 2013 PMID: 23451144 PMCID: PMC3581535 DOI: 10.1371/journal.pone.0057057
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Patients Characteristics.
| Patients Characterictics | Isolated patients (n = 111) | Controls (n = 111) | p-Value |
|
| 80.0 (69.0–86.0) | 80.0 (68.0–86.0) | 0.92 |
|
| 44 (39.6%) | 44 (39.6%) | 1.00 |
|
| |||
|
| 35 (31.5%) | 35 (31.5%) | 1.00 |
|
| 65 (68.5%) | 65 (68.5%) | 1.00 |
|
| 7.0 (3.0–13.0) | 6.0 (4.0–10.0) | 0.08 |
|
| 7.0 (5.0–9.0) | 7.0 (4.0–9.0) | 0.37 |
|
| 51.9 (35.1–72.4) | 51.6 (36.5–74.0) | 0.44 |
|
| 55.0 (37.5–60.0) | 50.0 (30.0–55.0) | 0.75 |
|
| 0.57±1.01 | 0.59±1.05 | 0.89 |
COPD : Chronic Pulmonary Obstructive Disease.
Assessment of Bedside Visits.
| Isolated patients(n = 111) | Controls(n = 111) | p-Value | |
|
| |||
|
| 139 | 111 | – |
|
| 134 | 110 | – |
|
| 116.5 | 114.9 | 0.90 |
|
| |||
|
| 452 | 417 | – |
|
| 399 | 399 | – |
|
| 347.0 | 416.9 | 0.01 |
|
| |||
|
| 653 | 528 | – |
|
| 444 | 432 | – |
|
| 454.5 | 451.4 | 0.02 |
|
| |||
|
| 1,244 | 1,056 | – |
|
| 977 | 941 | – |
|
| 849.6 | 983.3 | 0.001 |
|
| 1,150 | 957 | – |
|
| 0.90 (0.69–1.0) | 1.0 (0.92–1.3) | 0.0001 |
Complications Description.
| Complication Category | Isolated patients (n = 111 patients) | Controls (n = 111 patients) | p-Value |
| Deaths | 10 | 11 | – |
| Pulmonary-related | 2 | 3 | – |
| Heart-related | 6 | 4 | – |
| Infection-related | 2 | 4 | – |
| Bleeding | 5 | 6 | – |
| Delirium | 3 | 11 | – |
| Immobilisation/falls | 7 | 2 | – |
| Infections | 9 | 3 | – |
| Dysglycemia | 0 | 4 | – |
| Gastro-intestinal | 1 | 3 | – |
| Renal/electrolytes | 11 | 11 | – |
| Arrhythmia | 0 | 5 | – |
| Myocardial infarction | 0 | 2 | – |
| Blood pressure | 2 | 1 | – |
| Heart failure | 2 | 1 | – |
| Medication error | 6 | 0 | – |
| Other | 4 | 2 | – |
|
| 60 | 62 | – |
|
| 0.57±1.01 | 0.59±1.05 | 0.89 |
|
| 52.2 | 64.8 | 0.40 |